as on September 17, 2025 at 1:29 am IST
Day's Low
Day's High
2.88%
Downside
1.44%
Upside
52 Week's Low
52 Week's High
75.09%
Downside
41.73%
Upside
Check Esperion Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$560.5M
EPS (TTM)
-0.0167
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.49
Industry PE ratio
-3.9281873111782475
P/B Ratio
0PEG Ratio
-4.78
EBITDA
-35.3M
Revenue (TTM)
268.1M
Profit Margin
-38.80%
Return On Equity TTM
43097300.00%
Track how Esperion Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Esperion Therapeutics, Inc. in the last 5 years
Lowest (0.00x)
September 17, 2025
Industry (-3.93x)
September 17, 2025
Today (-3.49x)
September 17, 2025
Highest (-0.50x)
June 30, 2023
Today’s Price to Earnings Ratio: -3.49x
Compare market cap, revenue, PE, and other key metrics of Esperion Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $560.5M | -92.68% | -3.49 | -38.80% | |
BUY | $18.0B | NA | 15.52 | 40.36% | |
BUY | $44.0B | NA | 21.51 | 13.81% | |
BUY | $14.0B | 38.31% | 41.69 | 13.88% | |
BUY | $65.4B | -8.86% | 25.38 | 27.83% |
The Esperion Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Esperion Therapeutics, Inc. investment value today
Current value as on today
₹1,61,047
Returns
₹61,047
(+61.05%)
Returns from Esperion Therapeutics, Inc. Stock
₹56,180 (+56.18%)
Dollar Returns*
₹4,867 (+4.87%)
Based on 14 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Esperion Therapeutics, Inc.. Average target price of $5.8
Get share price movements and forecasts by analysts on Esperion Therapeutics, Inc..
What analysts predicted
52.07%UPSIDE
Target Price
$5.8
Current Price
$2.78
Analyzed by
14 Analysts
Target
$5.80
Esperion Therapeutics, Inc. target price $5.8, a slight upside of 52.07% compared to current price of $2.78. According to 14 analysts rating.
Investment in Esperion Therapeutics, Inc. Shares on INDmoney has grown by 33.33% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:33.33% versus previous 30 day period
Search interest for Esperion Therapeutics, Inc. Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, -40.45M → -4.79M (in $), with an average increase of 744.4% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 64.99M → 82.38M (in $), with an average increase of 21.1% per quarter
Price Rise
In the last 1 month, ESPR stock has moved up by 35.1%
Best in 1 Year
In the last 1 year, ESPR has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 3 years, United Therapeutics Corporation has given 82.5% return, outperforming this stock by 143.0%
Organisation | Esperion Therapeutics, Inc. |
Headquarters | 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108 |
Industry | Health Technology |
CEO | Mr. Sheldon L. Koenig |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Stephen Pinkosky | Vice President of Drug Discovery of Early Pre-Clinical Development |
Mr. Sheldon L. Koenig | President, CEO & Director |
Mr. Benjamin Halladay M.B.A. | Chief Financial Officer |
Mr. Benjamin O. Looker J.D. | General Counsel & Corporate Secretary |
Tiffany Aldrich M.B.A. | Associate Director of Corporate Communications |
Ms. Betty Jean Swartz | Chief Business Officer |
Mr. Glenn P. Brame | Chief Technical Operations Officer |
Esperion Therapeutics, Inc. share price today is $2.78 as on at the close of the market. Esperion Therapeutics, Inc. share today touched a day high of $2.82 and a low of $2.7.
Esperion Therapeutics, Inc. share touched a 52 week high of $3.94 on and a 52 week low of $0.69 on . Esperion Therapeutics, Inc. stock price today i.e. is closed at $2.78,which is 29.44% down from its 52 week high and 301.44% up from its 52 week low.
Esperion Therapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Esperion Therapeutics, Inc. (ESPR) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Esperion Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Esperion Therapeutics, Inc. share’s latest price of $2.78 as on September 17, 2025 at 1:29 am IST, you will get 3.5971 shares of Esperion Therapeutics, Inc.. Learn more about
fractional shares .
Esperion Therapeutics, Inc. stock has given -92.68% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?